Methods for treating bleeding disorders

Details for Australian Patent Application No. 2009284393 (hide)

Owner Baxter International Inc. Baxter Healthcare S.A.

Inventors Dockal, Michael; Scheiflinger, Friedrich; Turecek, Peter

Agent Peter Maxwell & Associates

Pub. Number AU-A-2009284393

PCT Pub. Number WO2010/020423

Priority 61/189,734 22.08.08 US

Filing date 21 August 2009

Wipo publication date 25 February 2010

International Classifications

A61K 31/737 (2006.01) - Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate

A61K 31/727 (2006.01)

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

27 January 2011 PCT application entered the National Phase

  PCT publication WO2010/020423 Priority application(s): WO2010/020423

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009284399-Endoprosthesis having a plug-in connection and improved rotary protection

2009284353-Crop safeners